£180m government funding to bridge the ‘valley of death’ for medical breakthroughs

£180m government funding to bridge the ‘valley of death’ for medical breakthroughs

11 Apr 2012

A £180 million government scheme that will provide grant funding for innovative small and medium sized enterprises (SMEs) and academics to develop solutions to healthcare challenges will open for applications at the end of April.

The Biomedical Catalyst is a key element of the Strategy for Life Sciences launched by the Prime Minister in December last year.  It will see the Medical Research Council (MRC) and the Technology Strategy Board working together to take the best British medical breakthroughs through to commercial success.

Promising ideas will be accepted from sectors or disciplines that demonstrate the potential to provide significant positive healthcare and economic impact.  Projects could focus on, for example, stratified therapy development, regenerative medicine, diagnostics, eHealth and mHealth solutions, enabling medical technologies and devices.  The programme will seek to support those opportunities which demonstrate the highest scientific and commercial potential, irrespective of medical area.

Three categories of grant awards will be available through the Biomedical Catalyst scheme – feasibility, early stage and late stage.  Any SME or academic undertaking research and development, either individually or working in collaboration, may apply and applications will be accepted at any time.   Individual grants to businesses will range from a maximum of £150,000 for feasibility awards to £3 million for early and late stage awards.

View more information about the Biomedical Catalyst here

View the press release here.

This video requires flash version 7 or higher to play.

Last updated on Friday 18 May 2012 at 16:06

More like this

See more content in the <Bioscience> <Medicines and healthcare> area

Copyright © 2013